Vulcan Capital, a private equity firm, completed a $10.5m Series A funding round in AMILI, a gut-biome startup, with participation from Seeds Capital, Emtek Group and Capital Code. “Although gut health research has advanced steadily over the years in other regions, there is still a big gap in research that is representative of the Asian population," Tommy Teo, Vulcan Capital Managing Director.